Alzheimer's Disease
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Tau, Pin1 and PARN target the expression of mRNAs deregulated in AD and/or cancer.
|
31749682 |
2019 |
Diabetic Nephropathy
|
0.010 |
Biomarker
|
disease |
BEFREE |
Grem1, SOST, and USAG1 have been demonstrated to be upregulated and play a critical role in the progression of diabetic nephropathy (DN); however, the expression and the role of other DAN family members in DN have not been reported yet.
|
30831151 |
2019 |
nervous system disorder
|
0.010 |
AlteredExpression
|
group |
BEFREE |
Tau induces PARN activity in different cellular models during DDR, and this activation is further increased by p53 and inhibited by tau phosphorylation at residues implicated in neurological disorders.
|
31749682 |
2019 |
Hereditary hemochromatosis
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Biallelic PARN mutations were associated with Høyeraal-Hreidarsson (HH) syndrome, a rare telomere biology disorder that, because of its severity, is likely not exclusively due to hTR down-regulation.
|
31273937 |
2019 |
Renal fibrosis
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
PARN mutations have been implicated in a short telomere syndrome characterized by lung, bone marrow, and liver fibrosis; these findings extend the phenotype of PARN mutations to renal fibrosis.
|
29204651 |
2018 |
Tumor Progression
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
Finally, in vivo study with immuno-competent syngeneic mice shows Z-DAN-11 to be able to impede tumor progression without any adverse side-effects.
|
29670107 |
2018 |
Fibrosis, Liver
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
PARN mutations have been implicated in a short telomere syndrome characterized by lung, bone marrow, and liver fibrosis; these findings extend the phenotype of PARN mutations to renal fibrosis.
|
29204651 |
2018 |
Tubulointerstitial fibrosis
|
0.010 |
GeneticVariation
|
phenotype |
BEFREE |
Among these, loss-of-function mutations were identified in PARN in 2 probands with tubulointerstitial fibrosis.
|
29204651 |
2018 |
Telomere Syndrome
|
0.010 |
GeneticVariation
|
phenotype |
BEFREE |
PARN mutations have been implicated in a short telomere syndrome characterized by lung, bone marrow, and liver fibrosis; these findings extend the phenotype of PARN mutations to renal fibrosis.
|
29204651 |
2018 |
Malignant neoplasm of breast
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Co-expression of both PARN and PLD2 mimicked this pattern in non-cancerous cells (COS-7 fibroblasts) but, surprisingly, not in breast cancer MCF-7 cells, where PARN switches from inhibition to activation of PLD2 gene and protein expression.
|
28011629 |
2017 |
Non-Small Cell Lung Carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
The mutation of codon 12 and 13, located in exon1 and exon 2 of k-RAS gene were examined by polymerase chain reaction (PCR) and DAN sequencing in tumor samples of the included 45 NSCLC patients.
|
28901317 |
2017 |
Incontinence
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
The reliability was assessed using Cronbach α and intraclass correlation coefficient (ICC) methods, and the validity using the correlations between the subgroup and overall scores of DAN-PSS and the scores of the Barthel Index (BI), International Consultation on Incontinence Questionnaire Short Form (ICIQ-SF), and Short Form 36 (SF-36).
|
28946578 |
2017 |
Triglyceride storage disease with ichthyosis
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
<b>Conclusion:</b> The DAN DB analysis shows that most dives were made in a "safe zone," even if data show an evident "gray area" in the "mathematical" ability to predict DCS by the current algorithms.
|
28974936 |
2017 |
Breast Carcinoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Co-expression of both PARN and PLD2 mimicked this pattern in non-cancerous cells (COS-7 fibroblasts) but, surprisingly, not in breast cancer MCF-7 cells, where PARN switches from inhibition to activation of PLD2 gene and protein expression.
|
28011629 |
2017 |
Lafora Disease
|
0.010 |
Biomarker
|
disease |
BEFREE |
Our study revealed that FC of ventral and dorsal attention networks DAN was reduced in LBD during all conditions, although most prominently during incongruent trials.
|
28391039 |
2017 |
Extrinsic allergic alveolitis
|
0.010 |
Biomarker
|
group |
BEFREE |
Heterozygous mutations in four telomere-related genes have been linked to pulmonary fibrosis, but little is known about similarities or differences of affected individuals.115 patients with mutations in telomerase reverse transcriptase (TERT) (n=75), telomerase RNA component (TERC) (n=7), regulator of telomere elongation helicase 1 (RTEL1) (n=14) and poly(A)-specific ribonuclease (PARN) (n=19) were identified and clinical data were analysed.Approximately one-half (46%) had a multidisciplinary diagnosis of idiopathic pulmonary fibrosis (IPF); others had unclassifiable lung fibrosis (20%), chronic hypersensitivity pneumonitis (12%), pleuroparenchymal fibroelastosis (10%), interstitial pneumonia with autoimmune features (7%), an idiopathic interstitial pneumonia (4%) and connective tissue disease-related interstitial fibrosis (3%).
|
27540018 |
2016 |
Connective Tissue Diseases
|
0.010 |
Biomarker
|
group |
BEFREE |
Heterozygous mutations in four telomere-related genes have been linked to pulmonary fibrosis, but little is known about similarities or differences of affected individuals.115 patients with mutations in telomerase reverse transcriptase (TERT) (n=75), telomerase RNA component (TERC) (n=7), regulator of telomere elongation helicase 1 (RTEL1) (n=14) and poly(A)-specific ribonuclease (PARN) (n=19) were identified and clinical data were analysed.Approximately one-half (46%) had a multidisciplinary diagnosis of idiopathic pulmonary fibrosis (IPF); others had unclassifiable lung fibrosis (20%), chronic hypersensitivity pneumonitis (12%), pleuroparenchymal fibroelastosis (10%), interstitial pneumonia with autoimmune features (7%), an idiopathic interstitial pneumonia (4%) and connective tissue disease-related interstitial fibrosis (3%).
|
27540018 |
2016 |
Fibroelastosis
|
0.010 |
Biomarker
|
disease |
BEFREE |
Heterozygous mutations in four telomere-related genes have been linked to pulmonary fibrosis, but little is known about similarities or differences of affected individuals.115 patients with mutations in telomerase reverse transcriptase (TERT) (n=75), telomerase RNA component (TERC) (n=7), regulator of telomere elongation helicase 1 (RTEL1) (n=14) and poly(A)-specific ribonuclease (PARN) (n=19) were identified and clinical data were analysed.Approximately one-half (46%) had a multidisciplinary diagnosis of idiopathic pulmonary fibrosis (IPF); others had unclassifiable lung fibrosis (20%), chronic hypersensitivity pneumonitis (12%), pleuroparenchymal fibroelastosis (10%), interstitial pneumonia with autoimmune features (7%), an idiopathic interstitial pneumonia (4%) and connective tissue disease-related interstitial fibrosis (3%).
|
27540018 |
2016 |
Pneumonia, Interstitial
|
0.010 |
Biomarker
|
disease |
BEFREE |
Heterozygous mutations in four telomere-related genes have been linked to pulmonary fibrosis, but little is known about similarities or differences of affected individuals.115 patients with mutations in telomerase reverse transcriptase (TERT) (n=75), telomerase RNA component (TERC) (n=7), regulator of telomere elongation helicase 1 (RTEL1) (n=14) and poly(A)-specific ribonuclease (PARN) (n=19) were identified and clinical data were analysed.Approximately one-half (46%) had a multidisciplinary diagnosis of idiopathic pulmonary fibrosis (IPF); others had unclassifiable lung fibrosis (20%), chronic hypersensitivity pneumonitis (12%), pleuroparenchymal fibroelastosis (10%), interstitial pneumonia with autoimmune features (7%), an idiopathic interstitial pneumonia (4%) and connective tissue disease-related interstitial fibrosis (3%).
|
27540018 |
2016 |
Idiopathic Interstitial Pneumonias
|
0.010 |
Biomarker
|
disease |
BEFREE |
Heterozygous mutations in four telomere-related genes have been linked to pulmonary fibrosis, but little is known about similarities or differences of affected individuals.115 patients with mutations in telomerase reverse transcriptase (TERT) (n=75), telomerase RNA component (TERC) (n=7), regulator of telomere elongation helicase 1 (RTEL1) (n=14) and poly(A)-specific ribonuclease (PARN) (n=19) were identified and clinical data were analysed.Approximately one-half (46%) had a multidisciplinary diagnosis of idiopathic pulmonary fibrosis (IPF); others had unclassifiable lung fibrosis (20%), chronic hypersensitivity pneumonitis (12%), pleuroparenchymal fibroelastosis (10%), interstitial pneumonia with autoimmune features (7%), an idiopathic interstitial pneumonia (4%) and connective tissue disease-related interstitial fibrosis (3%).
|
27540018 |
2016 |
Mental disorders
|
0.010 |
GeneticVariation
|
group |
BEFREE |
We identified large monoallelic deletions in PARN in four patients with developmental delay or mental illness.
|
26342108 |
2015 |
Neoplasm Metastasis
|
0.010 |
AlteredExpression
|
phenotype |
BEFREE |
PARN overexpression correlated with younger patient age and CNOT6 overexpression with non-metastatic tumors.
|
26541675 |
2015 |
Pancytopenia
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Biallelic PARN mutations cause severe bone marrow failure and central hypomyelination.
|
26342108 |
2015 |
Squamous cell carcinoma of lung
|
0.010 |
Biomarker
|
disease |
BEFREE |
Our results highlight the clinical significance of PARN and NOC on the survival in SCC diagnosed patients.
|
26541675 |
2015 |
Developmental delay (disorder)
|
0.010 |
GeneticVariation
|
phenotype |
BEFREE |
We identified large monoallelic deletions in PARN in four patients with developmental delay or mental illness.
|
26342108 |
2015 |